Heterogeneous Nuclear Ribonucleoprotein A3 Is the Liver Nuclear Protein Binding to Age Related Increase Element RNA of the Factor IX Gene by Hamada, Toshiyuki et al.
Heterogeneous Nuclear Ribonucleoprotein A3 Is the
Liver Nuclear Protein Binding to Age Related Increase
Element RNA of the Factor IX Gene
Toshiyuki Hamada
¤, Sumiko Kurachi, Kotoku Kurachi*
Age Dimension Research Center, National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki, Japan
Abstract
Background: In the ASE/AIE-mediated genetic mechanism for age-related gene regulation, a recently identified age-related
homeostasis mechanism, two genetic elements, ASE (age-related stability element) and AIE (age-related increase element as
a stem-loop forming RNA), play critical roles in producing specific age-related expression patterns of genes.
Principal Finding: We successfully identified heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3) as a major mouse
liver nuclear protein binding to the AIE-derived RNAs of human factor IX (hFIX) as well as mouse factor IX (mFIX) genes.
HnRNP A3 bound to the AIE RNA was not phosphorylated at its Ser
359, while hnRNP A3 in the mouse liver nuclear extracts
was a mixture of phosphorylated and unphosphorylated Ser
359. HepG2 cells engineered to express recombinant hFIX
transduced with adenoviral vectors harboring an effective siRNA against hnRNP A3 resulted in a substantial reduction in
hFIX expression only in the cells carrying a hFIX expression vector with AIE, but not in the cells carrying a hFIX expression
vector without AIE. The nuclear hnRNP A3 protein level in the mouse liver gradually increased with age, while its mRNA level
stayed age-stable.
Conclusions: We identified hnRNP A3 as a major liver nuclear protein binding to FIX-AIE RNA. This protein plays a critical
role in age-related gene expression, likely through an as yet unidentified epigenetic mechanism. The present study assigned
a novel functional role to hnRNP A3 in age-related regulation of gene expression, opening up a new avenue for studying
age-related homeostasis and underlying molecular mechanisms.
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Introduction
We previously reported the first molecular mechanism of age-
related homeostasis, the ASE/AIE-mediated genetic mechanism
for age-related gene expression [1–3]. In this mechanism, two
genetic elements, designated as ASE (age-related stability
element) and AIE (age-related increase element), play essential
roles for producing age-related stable and age-related increase
profiles of a gene expression, respectively. ASE functions
independently of AIE, while AIE requires ASE for generating a
fully age-related increase pattern of gene expression. More
recently, we further demonstrated the clinical relevance of this
mechanism by proving its critical role in the pathological
mechanism of hemophilia B Leyden, a subfamily of hemophilia
B showing unique puberty-onset amelioration, and showed that
this mechanism actually functions as a puberty-onset gene switch
mechanism [4]. A specific liver protein binding to the functional
ASE (only G/CAGGAAG out of all heptanucleotide combina-
tions) was identified as Ets1 [4].
AIEoriginallyidentifiedinthe hFIXgenehasa 102 basepair(bp)
stretch of dinucleotide repeats (rich in AT, GT and CA) in the
middle of 39-untranslated region (39-UTR), which potentially forms
and functions as a stem-loop RNA structure (hereafter referred as
hFIX-AIE RNA) after the gene is transcribed [1,2,5]. The mFIX
gene also shows an age-related increase expression pattern [1], and
has a stretch of dinucleotide repeats (rich in AT) of about a 50 bp in
the middle of 39-UTR, potentially forming a stem-loop RNA
structure (referred as mFIX-AIE RNA) after gene transcription [2].
Both hFIX-AIE RNAand mFIX-AIE RNA function equally well in
a position-dependent and orientation-independent manner for
producing an age-related increase pattern of gene expression as
tested with the human protein C gene, lacking AIE [2].
In this report, we describe identification of hnRNP A3 as the
mouse liver nuclear protein, which specifically bind to hFIX-AIE
RNA as well as to mFIX-AIE RNA, its phosphorylation status in
binding to AIE RNA, functional characterization analyzed by
siRNA and age-related expression profiles of its gene and protein,
thus assigning a novel functional role to this protein.
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Specific binding of liver nuclear protein(s) to hFIX-AIE
RNA and mFIX-AIE RNA
As shown in Figure 1A, electrophoretic mobility shift assay
(EMSA) of mouse liver nuclear extracts (NEs) with
32P-hFIX-AIE
RNA resulted in two major mobility shifted bands with increasing
amounts of NEs (lanes 5–7), suggesting that hFIX-AIE RNA
specifically bind at least two nuclear proteins. Intensities of these
bands drastically reduced with addition of excess amounts of non-
radiolabeled hFIX-AIE RNA (Fig. 1A, lanes 8–10), confirming the
specificity of protein binding to the hFIX-AIE RNA probe. As
shown in Fig. 1B,
32P-mFIX-AIE RNA probe also produced
similar two shifted bands with increasing amounts of NEs (lanes 3
and 4), and their intensities again efficiently reduced by addition of
non-radiolabled mFIX-AIE RNA probe (lanes 5 and 6) as well as
of non-radiolabled hFIX-AIE RNA (lane 7). The shifted bands
generated with
32P-hFIX-AIE RNA (lane 8) were also efficiently
reduced with addition of non-radiolabled mFIX-AIE RNA (lane
9), indicating that both hFIX-AIE RNA and mFIX-AIE RNA
likely bind same nuclear proteins. Reflecting the smaller size of
mFIX-AIE RNA (50 nucleoside residues) than that of hFIX-AIE
RNA (149 nucleoside residues) used, the band shifts produced with
32P-mFIX-AIE RNA (Fig. 1B, lanes 3 and 4) were smaller than
 
                                  
 
         
   
 
   
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
                     
Figure 1. EMSAs and SDS-PAGE analyses of
32P-hFIX-AIE RNA/nuclear protein and
32P-mFIX-AIE RNA/nuclear protein complexes. A.
EMSAs of
32P-hFIX-AIE RNA with liver NEs. Various conditions tested are shown at the top. Brackets on the left indicate hFIX-AIE RNA probe-protein
complexes and degraded
32P-hFIX-AIE RNA as shown. The position of free
32P-hFIX-AIE RNA is shown with a short horizontal bar on the left. Lanes 1, 2
and 5–10 contain
32P-hFIX-AIE RNA. Lane 2, treated with RNase T1; lanes 3 and 4, null controls; lanes 5–7, with increasing amounts of liver NEs; lanes
8–10, with NEs (10 mg) and increasing amounts of cold hFIX-AIE RNA competitor. B. EMSAs of
32P-mFIX-AIE or
32P-hFIX-AIE RNA with liver NEs. Lanes
1–7 contains
32P-mFIX-AIE RNA, while lanes 8 and 9 contain
32P-hFIX-AIE RNA. Positions of the AIE RNA probe-protein complex, free AIE RNA probe
and degraded probe are similarly shown as in A. Lane 1, without NEs; lane 2, treated with RNase T1; lanes 3 and 4, with increasing amounts of NEs;
lanes 5 and 6, with NEs (10 mg) and increasing amounts of cold mFIX-AIE RNA competitor; lane 7, with NEs (10 mg) and cold hFIX-AIE RNA; lane 8, with
NEs (10 mg); lane 9, with NEs (10 mg) and cold mFIX-AIE RNA. C. SDS-PAGE analysis of UV cross-linked
32P-hFIX-AIE RNA/nuclear protein complex
treated with RNase T1 (lane 1), RNase A/T1 (lane 2) and no RNase treatment (lane 3). Brackets a and b represent the positions of AIE RNA-protein
complex without and with RNase-treatment, respectively. Size marker positions are shown on the left. D. SDS-PAGE analysis of UV cross-linked and
RNase T1-treated
32P-hFIX-AIE RNA incubated with increasing amounts of NEs. Positions for the AIE RNA/protein complex and degraded
32P-hFIX-AIE
RNA are shown with brackets on the right. Lane 1, protein size marker with sizes shown on the left. E. SDS-PAGE analysis after competitive EMSAs of
32P-hFIX-AIE RNA with cold hFIX-AIE RNA (lanes 2–4), and with poly(U), poly(A) and poly(C) (lanes 5–6). Other conditions are similar to D.
doi:10.1371/journal.pone.0012971.g001
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32P-hFIX-AIE RNA (lane 8). When hFIX-
AIE RNA probe/protein complexes were UV cross-linked, two
bands of approximate 44 kDa (major) and 50 kDa (minor) shown
with bracket a were observed in sodium dodecylsulfate polyacryl-
amide gel electrophoresis (SDS-PAGE), and with subsequent
RNase treatments, their sizes lowered to about 40 and 45 kDa
shown with bracket b, respectively, presumably due to a loss of the
RNase-accessible portions of RNA fragment (Fig. 1C). Similar
reductions in size were also seen with UV cross-linked and RNase-
treated
32P-mFIX-AIE RNA/nuclear protein complex (data not
shown). Two major mobility shifted bands observed for the UV
cross-linked and RNase-treated hFIX-AIE RNA increased their
band intensities with increasing amounts of NEs used (Fig. 1D,
lanes 2–4), supporting the specific nuclear protein binding to
32P-
hFIX-AIE RNA shown by band-shift assays (Fig. 1A, lanes 5–7).
Competitive reductions in the intensity of
32P-hFIX-AIE RNA/
nuclear protein complex bands observed with addition of the cold
hFIX-AIE RNA probe (Fig. 1A, lanes 8–10) were maintained
through UV cross-linking/RNase-treatment processes, indicating
that the complex formation is specific and not a false event
(Fig. 1C, D).
In a separate series of experiment with non-specific homo-poly
nucleosides, homo-poly(C), showed no significant competition in
RNA EMSA, while homo-poly(U) and homo-poly(A) showed
significant competitions on formation of
32P-hFIX-AIE RNA/
nuclear protein complex. The competition, however, was
significantly weaker than that with cold hFIX-AIE RNA (Fig. 1E).
Identification of hnRNP A3 as the liver nuclear protein
specifically binding to FIX-AIE RNA
A sufficient amount of
32P-hFIX-AIE RNA/protein complex
required for preparative solution-phase isoelectric focusing (IEF)
was obtained by repeating the procedures of RNA EMSA with the
32P-hFIX-AIE RNA probe, UV-irradiation and RNase digestion
of the
32P-hFIX-AIE RNA probe/protein complex extracted,
SDS-PAGE separation, subsequent excision of the radio-active gel
area corresponding to 30 kDa–60 kDa and extraction of the
treated complex by electro-elution. Two dimensional electropho-
resis (2DE) analyses of the complex samples showed that the
solution-phase IEF efficiently concentrated the most
32P-hFIX-
AIE RNA/protein complex to pH 4.6–5.4 zone (Fig. 2A, b), a
much less, but significant amount to pH 3–4.6 zone (Fig. 2A, a),
and only very low or negligible amounts to pH 5.4–6.4 and
pH 6.4–7.0 zones (Fig. 2A, c and d, respectively). Subsequent
2DE (Fig. 2B) and autoradiography (Fig. 2C) of the pooled
solutions of pH 3–4.6 and pH 4.6–5.4 zones identified distinct
multiple radioactive gel spots with the major one centered at
pH 4.5 and 43 kDa in molecular size. Matrix-assisted laser
desorption/ionization-time-of-flight mass-spectrometer (MALDI-
TOF/MS) and Peptide mass fingerprint (PMF) analyses of the
proteins extracted from the major radioactive gel spot reproduc-
ibly identified mouse hnRNP A3 (UniProtKB/Swiss-Prot acces-
sion number: Q8BG05) as the only protein component (p,0.05)
with a high Mascot score of 152 (Fig. 3A). Similar analyses of
32P-
mFIX-AIE RNA probe/nuclear protein complexes also identified
hnRNP A3 as the only protein component with a high Mascot
score of 117 (Fig. 3B). In these analyses, both two known hnRNP
A3 isoforms, hnRNP A3a (full-length form) and hnRNP A3b (a
short form due to an alternative splicing) [6–8] were detected
together (here, their names were redefined to eliminate previously
existing minor ambiguities). Four independent experiments, two
with
32P-hFIX-AIE RNA and two with
32P-mFIX-AIE RNA,
reproducibly identified hnRNP A3 as the nuclear protein binding
to these AIE RNA probes. In one of the two experiments with
hFIX-AIE RNA, however, hnRNP A2/B1 was also detected
(UniProtKB accession number: O88569), although not at very
significant level (Mascot score 53, p=0.072) in addition to hnRNP
A3. Since no hnRNP A2/B1 as well as other proteins were
detected in all other three independent experiments with both
hFIX-AIE RNA and mFIX-AIE RNA, hnRNP A3 was deter-
mined to be a major AIE RNA binding nuclear protein. In 2DE,
the FIX-AIE RNA/hnRNP A3 complex migrated to pI3-5.4
shifting from the expected pI7-9 for the free form of hnRNP A3
[9–11], apparently due to the bound RNA probe.
In MALDI-TOF/MS analyses carried out, a mass-spectrum m/
z 1910.8 or 1910.9 corresponding to the peptide spanning amino
acid (aa) 356–377 (SSGSPYGGGYGSGGGSGGYGSR; see
Fig. 3) with its Ser
359 (Fig. S1) unphosphorylated was reproducibly
detected, while a mass-spectrum m/z 1990.8 corresponding to the
peptide with the Ser
359 residue phosphorylated (Fig. S1), was
always absent (Fig. 4A and B). The aa numbering system used here
included the first methionine residue as aa 1 so that the numbering
is consistent with that customarily used for this protein [6].
Phosphorylation status at Ser
359 of hnRNP A3 protein
2DE and subsequent MALDI-TOF/TOF/MS (MALDI-
TOF2) analyses of liver NEs obtained from mice at 3 months of
age identified at least 19 protein spots to contain hnRNP A3 (data
not shown). By definition of Mascot scores $53 being significant,
14 and 5 of these spots were found to contain only hnRNP A3
protein and mixtures of proteins including hnRNP A3, respec-
tively. Four of the 14 hnRNP A3 single protein spots contained
hnRNP A3 with its Ser
359 phosphorylated (Fig. S1), while others
contained hnRNP A3 with its Ser
359 unphosphorylated. As shown
in Fig. 4C, however, MALDI-TOF2 analyses of these four hnRNP
A3 protein spots reproducibly detected both mass-spectra m/z
1910.9 and m/z 1990.8, indicating that Ser
359 in the above
mentioned peptide (aa 356–377) is in a mixed state of unpho-
sphorylated and phosphorylated. Liver nuclear proteins prepared
from 6 month-old mice had the same number of protein spots of
hnRNP A3 with their Ser
359 residues phosphorylated in a similar
2DE separation pattern found for 3 month-old animals, while liver
nuclear proteins prepared from animals at 18 and 21 months of
age showed two more hnRNP A3 protein spots with their Ser
359
phoshorylated (data not shown). Both mass-spectra m/z 1910.9
and m/z 1990.8 were always observed with hnRNP A3 protein
obtained from these spots. In the present study, Ser
359 was most
candidate phosphorylation site (Fig. S1) and no evidence for
possible phosphorylation of aa residues other than Ser
359.
Furthermore, 2DE analyses of the cytosol proteins were unable
to detect any hnRNP A3 containing protein spots, likely due to its
very low concentration in the liver cell cytosol fraction.
Effects of siRNA against hnRNP A3 on hFIX minigene
expression in HepG2 cells
Six different candidate siRNA sequence sites of the gene
encoding hnRNP A3 were selected as described in the methods
section (Table 1). The efficacy of each siRNA in inhibiting the
expression of hnRNP A3 in 293T cells co-transfected with hnRNP
A3 expressing plasmid and corresponding siRNA expression
vector plasmid was analyzed in quantitative reverse transcription
(RT)-polymerase chain reaction (RT-PCR) experiments (Fig. 5A).
PCR primers for hnRNP A3 and GAPDH (control) used in these
quantitative RT-PCR assays were 59-GTATGGCAAGATT-
GAAACCATAGAG-39 and 59-GCCCATTAATAGTGTGG-
TATTTCTG -39, and 59-AAATGGTGAAGGTCGGTGTG-39
and 59-TGAAGGGGTCGTTGATGG-39, respectively. Among
the six siRNA vectors against hnRNP A3 prepared, one (siRNA 6)
AIE Binding Protein
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hnRNP A3 gene (Genebank accession number: AB201711, nt 1–
1636), reproducibly reduced the hnRNP A3 mRNA level by
approximately 78% in 293T cells, the largest suppression of
hnRNP A3 expression (Fig. 5A), and was used for the subsequent
experiments. A scrambled siRNA against hnRNP A3 (siRNA 7)
(59-acaagagcgaaccagcactt-39, a randomized sequence of nt 113
through 132 of the hnRNP A3 gene) and a siRNA against green
fluorescent protein (GFP)(siRNA 8) (Genebank accession number:
AF435433.1; 59- ggagttgtcccaattcttg-39) were used as the controls
(Table1). Upon delivering adenoviral vectors harboring siRNA 6
into the tail veins of mice (C57BL6/J), the hnRNP A3 mRNA
level in the liver was lowered to 49% and 54% on day 4 and day
14, respectively, of that obtained by injection of PBS-saline
(Fig. 5B).
Effects of transduction with adenoviral vectors harboring the
most effective siRNA, siRNA 6, and its target sequence scrambled
siRNA on hFIX expressions from HepG2 cells transfected in
advance with -416FIX m1/1.4 and -416FIX m1, hFIX minigene
expression vectors with and without AIE, respectively, are shown
in Table 2. HepG2 cells transfected with -416FIXm1 and
subsequently transduced with adenoviral vectors harboring siRNA
6 against hnRNP A3 or its scrambled siRNA control at
multiplicities of infection (MOI) 2, 20 and 100 showed no
reductions in hFIX expression over that of the cells treated with
PBS-saline (control) at any MOI tested (Table 2). However,
HepG2 cells transfected with -416FIX m1/1.4 and subsequently
transduced with the same adenoviral vector harboring siRNA 6
showed 4, 14 and 36% reductions in hFIX expression level at
MOI 2, 20 and 100, respectively, over that of PBS-saline control
(P,0.05, Student9s t-test). In a similar experiment, no such
reductions were observed with adenoviral vectors harboring the
scrambled siRNA 6.
Age-related expression profiles of the hnRNP A3 gene in
the mouse liver
An expression profile of the hnRNP A3 gene (mRNA level)
observed for a period of 1 through 21 months of age is shown in
Fig. 6A (top panel). For RNase protection assays (RPA) used in this
analysis, a DNA fragment designed to protect a RNA fragment of
256 nucleoside residues in size was generated by PCR using
forward and reverse primers, 59-atggaagacaggcagagt-39 and 59-
taatacgactcactataggagtttcctccacgaccaa-39, respectively. A similar
RPA analysis of mouse b-actin RNA (control for RPA) gave an age
profile of a RNA fragment of 245 nucleoside residues in length
(Fig. 6A, bottom panel). An age profile of the ratio of the protected
hnRNP A3 mRNA band intensity divided by that of b-actin
showed no significant age-related changes over the tested period
   
     
 
Figure 3. Amino acid sequences of mouse hnRNP A3 in complex with hFIX-AIE RNA and mFIX-AIE RNA. Amino acid sequences of mouse
liver hnRNP A3 (isoform hnRNP A3a) bound with hFIX-AIE RNA (A) and mFIX-AIE RNA (B), identified by MALDI-TOF/MS and subsequent Mascot search
analyses, are shown in bald letters of its known complete sequence [6]. Underlines indicate the sequence region absent in hnRNP A3b, a short
isoform of hnRNP A3 generated by an alternative splicing [6]. In the present mass-spectrometric analyses, no discrimination between hnRNP A3a and
hnRNP A3b was made. Domain structures in analogy to other known hnRNP family proteins include RRM 1 (RNA recognition motif: aa 35–118), RRM 2
(RNA recognition motif: aa 126–205) and RGG motif (aa 211–379) [6–8].
doi:10.1371/journal.pone.0012971.g003
Figure 2. 2DE analysis of UV cross-linked/RNase-treated
32P-hFIX-AIE RNA/liver nuclear protein complex and its autoradiography.
A. Analytical scale 2DE analyses of the solution-phase IEF chamber solutions containing UV cross-linked/RNase-treated
32P-hFIX-AIE RNA/protein
complexes. Chamber solutions of pH 3–4.6, pH 4.6–5.4, pH 5.4–6.4 and pH 6.4–7.0 zones were subjected to analytical 2DEs using immobilized pH 4–
7 gradient gels for IEF and 4–12% gradient gel SDS-PAGE, and the results are shown in panels a, b, c and d, respectively. B. Silver-stained 2DE gel of
UV cross-linked and RNase-treated
32P-hFIX-AIE RNA/nuclear protein complexes concentrated to pH 3–4.6 and pH 4.6–5.4 chambers in the solution
phase IEF. Molecular size marker proteins are shown on the left edge of the gel with their sizes. Arrow indicates the protein spot position matching
with the center of the major radioactive spot detected by autoradiography. C. Autoradiogram of the gel shown in B. Arrow indicates the center of the
major radioactive spot, and the gel recovered from this center area was subjected to subsequent MALDI-TOF/MS analysis.
doi:10.1371/journal.pone.0012971.g002
AIE Binding Protein
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18S RNA fragment of 80 nucleoside residues (data not shown).
Two major hnRNP A3 protein bands of approximately 38 kDa
and 41 kDa identified by Western blot analysis of the liver NEs
apparently corresponded to hnRNP A3a and A3b isoforms,
respectively [6,7] (Fig. 6C). In contrast to an age-stable profile
observed for the hnRNP A3 mRNA level, these protein levels
gradually increased along the age-axis (Fig. 6D). Rabbit polyclonal
anti-hnRNP A3 antibody used in this experiment was produced by
using a mixture of two synthetic peptides of mouse hnRNP A3
sequences, FGGDGGNYGGGPGYSS (aa 270–285) and GYD-
GYNEGGNFG (aa 309 through 320) as antigens (see reference 6
for the aa sequence system).
Discussion
As we previously reported [1,2], the ASE/AIE-mediated genetic
mechanism for age-related gene regulation has two essential
elements, ASE and AIE. Together with other basal regulatory
elements, these elements produce a unique age-related gene
expression profile, and identification of their binding proteins in
the nucleus remained critical for gaining insights into the age-
related homeostasis mechanism. Recently, Ets1 was successfully
identified as the liver protein binding to ASE [4], while
identification of the nuclear proteins binding to AIE RNA
remained to be achieved.
In the present study, a series of RNA EMSAs with mouse liver
NEs and hFIX-AIE RNA or mFIX-AIE RNA reproducibly
detected two shifted bands for both RNA probes (Fig. 1).
Subsequent 2DE of a pooled sample of the UV-irradiated and
RNase treated
32P-hFIX-AIE RNA/nuclear protein complex
identified well-defined radioactive protein spots (Fig. 2). By
performing repeatedMALDI-TOF/MS andPMF analysesof the
major radioactive protein spot, we successfully identified hnRNP
A3, a hnRNP family protein [8], as a major nuclear protein
binding to hFIX-AIE RNA (Fig. 3). Inonly one experiment outof
four independent experiments (two experiments for each mFIX-
and two hFIX-AIE RNA probes), hnRNP A2/B1, another
Figure. 4. MALDI-TOF/MS spectra of peptides generated from mouse hnRNP A3 in complex with hnFIX-AIE RNA and mFIX-AIE RNA,
and with no AIE RNA. A. Cropped mass spectra of the 2DE protein spot containing the UV-irradiated and RNase-treated
32P-hFIX-AIE RNA/hnRNP
A3 complex. Mass-spectrum m/z 1910.8 corresponding to a tryptic peptide of hnRNP A3 (aa 356 through 377) with Ser
359 unphosphorylated was
reproducibly detected, while mass-spectrum m/z 1990.8 corresponding to the same peptide with phosphorylated Ser
359 was not detected. B.
Cropped mass spectra of the 2DE protein spot containing the UV-irradiated and RNase-treated
32P-mFIX-AIE RNA/hnRNP A3 complex. Experimental
conditions used and observations made were similar to those described in A. C. Cropped mass spectra of one of protein spots separated in 2DE of
liver NEs (free of hnRNP-AIE RNA). Both spectra m/z 1910.9 and m/z 1990.8 were reproducibly detected.
doi:10.1371/journal.pone.0012971.g004
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A3. However, because of its inconsistency in binding to AIE
RNA probes, a possible role of this protein in age-related
regulation of gene expression is likely minor, if any. Two shifted
bands reproducibly observed with AIE RNA probes (Fig. 1)
presumably correspond to two known major isoforms, hnRNP
A3a and A3b of 41 and 38 kDa in size, respectively (see Fig. 3)
[6–8]. These two mouse liver isoforms of hnRNP A3 are known
to have 379 and 357 aa residues, respectively. Whether or not
both isoforms function equally well in age-related homeostatic
regulation of genes remains to be determined. We also observed
two additional bands with much weaker intensities in Western
blot analyses (Fig. 6C). These may correspond to additional two
minor hnRNP A3 isomers previously detected by Ma et al. [6] in
Western blot analysis, but not in LC/mass-spectrometric
analysis.
Both hFIX-AIE RNA and mFIX-AIE RNA, which are
particularly rich in AT repeats as the common structures,
specifically bind hnRNP A3 and function in a similar manner in
age-related gene regulation. This is in accordance with the fact
that in RNA EMSA competition assay, both homo-poly(U) and
homo-poly(A) show significant competitive effects on hnRNP A3
binding to AIE RNAs, while homo-poly (C) does not, suggesting a
preference of AT-rich nucleoside sequences by hnRNP A3 in its
binding to AIE RNA (Fig. 1E). Although hFIX-AIE RNA, and not
mFIX-AIE RNA, contains some GU and CA repeats, they appear
not important in binding to hnRNP A3. In addition, we speculate
that for specific binding by hnRNP A3, stem-loop structures of
AIE RNAs also play an important role [5]. Further studies,
however, are required for better understanding of the AIE RNA
structure and hnRNP A3 binding relationship.
MALDI-TOF/MS analyses of the UV cross-linked hnRNP A3/
hFIX-AIE RNA complex never detected specific peptides
encompassing the region aa 100–126 (Fig. 3), while similar
analyses of AIE RNA-free hnRNP A3 detected the peptides of this
region (data not shown). This observation suggests that this region
in the immediate neighborhood of a RNA recognition motif
(RRM) known for hnRNP family proteins [12–14] may be a part
of AIE-RNA binding site of hnRNP A3. Further studies are
needed to clarify actual roles in RNA binding of this region as well
as Gly-rich regions containing several Arg-Gly-Gly motifs in RNA
binding, which have been previously implicated in RNA binding
of various hnRNP family proteins [12–14].
In MALDI-TOF/MS analyses of the nuclear hnRNP A3 in
complex with the hFIX-AIE RNA, a mass-spectrum m/z 1910.9,
which corresponds to the peptide aa 356–377 with its Ser
359
Figure 5. Construction of siRNAs against hnRNP A3 and their
effects on hnRNP A3 expression. A. Suppressive effects of siRNA 1–
6 (siRNA against hnRNP A3) on the hnRNP A3 mRNA level in 293T cells.
Effects of siRNA were assessed in duplicates in 293T cells co-transfected
with expression vector plasmids for hnRNP A3 and various siRNA
expression vectors as shown in Table 1. Averages of two independent
assays of each duplicated measurements per condition were normal-
ized to siRNA 7 (scrambeled siRNA 6) for presentsation. Thin vertical
lines with short horizontal bars represent ranges of the duplicated
measurements. B. Relative hnRNP A3 mRNA levels in the mouse liver
post-injection of adenoviral vectors harboring siRNA 7 and siRNA 6.
Animals were injected with the adenoviral vectors harboring siRNA 7,
siRNA 6 or PBS-saline (n=4 for each condition), and on day 4 and day
14 post-injection, hnRNP mRNA levels in the liver were measured. The
results are normalized to that of b-actin mRNA, and their mean relative
values over that of the PBS-saline condition (no siRNA, and defined as 1)
are shown. Thin vertical lines with short horizontal bars represent S.D.
doi:10.1371/journal.pone.0012971.g005
Table 1. Nucleotide sequences of hnRNP A3 used as targets
for constructing siRNAs and of control siRNAs.
Target sequences of siRNAs designed to hnRNP A3 and control siRNA
siRNA 1 GCAACAATCAAATTATGGA (1056–1074)
siRNA 2 GGAAGAATATAACCTGAGA (450–468)
siRNA 3 CCATAGAGGTTATGGAAGA (500–518)
siRNA 4 GGATATGGTAGCAGAAGGT (1156–1174)
siRNA 5 GCACACTTACAGACTGTGT (215–233)
siRNA 6 GCCATGATCCAAAGGAACCA(113–132)
siRNA 7 ACAAGAGCGAACCAGCACTT(scrambled siRNA6)
siRNA 8 GGAGTTGTCCCAATTCTTG (siRNA against GFP)
doi:10.1371/journal.pone.0012971.t001
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to the same peptide with its Ser
359 phosphorylated was always
absent (Fig. 4, A and B). In contrast, RNA fragment-free liver
nuclear hnRNP A3 reproducibly gave both m/z 1910.9 and m/z
1990.8, indicating that the Ser
359 residue is in both states of
partially unphosphorylated and phosphorylated (Fig. 4C). Here,
m/z 1910.9 detected could be in part due to a partial release of the
phosphate group from the once phosphorylated Ser
359 residue in
the fragmentation process of the protein in MALD-TOF/MS
analysis. The phosphorylated status of Ser
359 is of particular
interest, because in analogy to other hnRNP proteins [11,15–20],
phosphorylation and dephosphorylation of this region of hnRNP
A3 likely play critical roles in regulation of FIX mRNA translation
and also intracellular recycling of hnRNP A3 itself. In a global
analysis, Villen et al. [20] found that Ser and Tyr residues in the
region (aa 356–377) of hnRNP A3 including Ser
359 are
phosphorylated. In the present study, however, we did not obtain
any evidence for phosphorylation of Ser and Tyr residues other
than Ser
359 (Fig. S1). Yamaoka et al. [11] reported that in the cells
transformed with temperature-sensitive Rous sarcoma virus, the
level of phosphorylated human hnRNP A3 at one or more of the
three serine residues present in the region aa 355 through 376
(equivalent to aa 356–359 in mouse hnRNP A3 due to the
presence of an extra aa residue G
309) increased with temperature.
HnRNP K, one of the hnRNP family proteins, is known to bind to
the differentiation control element (DICE), a CU-rich stretch of
sequence in the 39-UTR of 15-lipoxygenase (LOX) mRNA,
inducing translational repression of the LOX gene [16]. This
repressive effect is removed upon tyrosine phosphorylation of the
protein [17]. Zipcode binding protein 1 (ZBP1), which binds to a
Table 2. Effects of siRNA 6 on hFIX expression from HepG2
cells transfected with -416FIXm1 (containing no AIE) and -
416FIXm1/1.4 (containing AIE).
Relative expression Activity (% ± SD)*
siRNA MOI -416FIIX m1 -416FIIX m1/1.4
PBS-saline 100 100
Scrambled siRNA 6 2 105616 100617
siRNA 6 2 109617 9669
Scrambled siRNA 6 20 100615 9866
siRNA 6 20 109621 86623
Scrambled siRNA 6 100 108623 98616
siRNA 6 100 104625 64621
#
*HepG2 cells transfected with hFIX minigene expression vector, -416FIXm1
(containing no AIE) or -416FIXm1/1.4 (containing AIE), were treated with PBS-
saline, or transduced with adenoviral particles harboring scrambled siRNA 6 or
siRNA 6, and hFIX protein produced was measured (n=4). Human FIX
expression activity was normalized to that of HepG2 cells treated with PBS-
Saline for each expression vector condition. SD, standard deviation. #P,0.05
(vs. scrambled siRNA6).
doi:10.1371/journal.pone.0012971.t002
                
               
 
 
 
 
Figure 6. Age-dependent levels of hnRNP A3 mRNA and protein in the mouse liver. A. Age-related changes of the hnRNP A3 mRNA level
determined by RPA. Total liver RNA preparation obtained from male C57BL6/J mice (n=4 per age point) was subjected to quantification by RPA. The
top and bottom panels are for hnRNP A3 and b-actin, respectively. Numbers at the bottom of the panels represent age of animals. Size marker
positions are shown on the left. B. The age-related profile of the relative hnRNP A3 mRNA level normalized to that of b-actin shown in A. C. Western
blot analysis of age-related hnRNP A3 protein levels in the mouse liver. Protein size marker positions are shown on the left, and age of animals are
shown at the bottom. Two major protein bands corresponding to the known isoforms, hnRNP A3a and hnRNP A3b, are depicted with a and b with
arrows on the right. D. The age-related increase profiles of hnRNP A3a and hnRNP A3b proteins observed in C.
doi:10.1371/journal.pone.0012971.g006
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prevents the mRNA from being used for translation, but again like
hnRNP K, upon phosphorylation of Tyr
396, it frees the bound
mRNA, allowing it to be used for translation [19]. Similar to other
hnRNP family proteins, hnRNP A3 is presumably regulated not
only by phosphorylation but also by various other types of
modifications including methylation [21,22] and sumoylation [23].
These various protein modifications in addition to alternative
splicings apparently give rise to many hnRNP A3 protein spots
detected in 2DE.
Our efforts for constructing effective adenoviral vectors
harboring siRNAs against hnRNP A3 resulted in identification
of a highly effective siRNA, siRNA 6, which was capable to reduce
the hnRNP A3 mRNA level by 78% in 293T cells (Fig. 5A). This
siRNA also lowered the hnRNP A3 mRNA level in mice to 49%
and 54% of that obtained with PBS-saline control on day 4 and
day 14, respectively (Fig. 5B). We then tested this construct for its
effects on hFIX expression from HepG2 cells transfected with -
416FIX m1, a hFIX expression vector without AIE, and -
416FIXm1/1.4, a hFIX expression vector containing AIE. These
hFIX expression vectors were previously characterized extensively
for their stable hFIX expression at substantial levels in HepG2 cells
[1]. Transduction of HepG2 cells carrying -416FIX m1 with and
without siRNA 6 containing adenovirual particles at various MOIs
showed no reduction in hFIX expression at all conditions tested
(Table 2). In a similar experiment, however, hFIX expression from
the HepG2 cells carrying -416FIXm1/1.4 showed siRNA-specific
and adenoviral MOI-dependent reductions in hFIX expression,
while no such reduction in expression was observed with the cells
transduced with scrambled siRNA 6 containing adenoviral
particles (Table 2). Together, these observations further support
the critical roles of AIE and its binding protein, hnRNP A3, in
hFIX expression.
The hnRNP A3 mRNA level in the mouse liver stays stable
throughout the tested period of age (1 through 21 months)
(Fig. 6A and B). In contrast, the concentration level of hnRNP A3
protein in the liver gradually increases in an age-dependent
manner (Fig. 6C and D). This discordance in the age-related
expression patterns of mRNA and protein of hnRNP A3
indicates that hnRNP A3 is under regulation of age-dependent
epigenetic events. This is different from what we observed for
HuR, an AU-rich RNA domain binding protein [24], showing
age-stable expression patterns for both mRNA and protein (data
not shown). Further detailed studies on the age-related regulation
of gene byhnRNP A3 with the siRNA using an animal model and
underlying mechanism of action of hnRNP A3 still remain to be
done.
HnRNP A3 is a recently found member of the hnRNP family
protein, currently composed of more than 20 different proteins
including hnRNP A1, A2, B1 and B0a/b, which are known to
have highly diverse functions such as precursor mRNA
processing, transcriptional regulation and DNA recombination
[6–8,25]. HnRNP A3 has been reported to bind to the telomere
sequence, likely playing an important role in its maintenance
[26], and to the 39-UTR region of the cyclooxygenase-2 gene,
playing a role in lipopolysaccharide signal transduction [10].
This protein is also known to bind to the AU-rich element in the
39-UTR region of TNFa gene, likely working as an inflammatory
mediator [9].
This study has successfully assigned a novel functional role to
hnRNP A3 in age-related regulation of gene expression, opening up
a new avenue for studying age-related homeostasis and underlying
molecular mechanisms, and for developingnew preventive methods
and treatments for relevant age-associated diseases.
Materials and Methods
Materials
Radiolabeled nucleoside, a [
32P]-UTP, and poly(U), poly(A)
and poly(C) homoribonucleoside oligomers were obtained from
GE Healthcare (Little Chalfont, UK). Antibodies used for hFIX-
specific enzyme-linked immunosorbent assay (ELISA) and HepG2
cell line were obtained as previously described [1,27].
Animals
Mice (C57BL/6J) at various ages were obtained from Charles
River Laboratories (Wilmington, MA). Animal care and use
were reviewed and approved by the Committee for Animal
Experimentation of the National Institute of Advanced
Industrial Science and Technology (AIST)(permission # 36-
07-009) and were performed in accordance with the institu-
tional guidelines of the Committee for Animal Experimentation
in the AIST.
Construction of AIE RNA probes
32P-labeled AIE RNA probes were prepared by using T7-
MEGAshortscript high yield kit according to the manufacture’s
instruction (Ambion, Austen, TX). In vitro transcription was done
for 2 h at 37uC with a template DNA fragment of 149 bps,
harboring hFIX-AIE region (102 bps). This template DNA
fragment was prepared by PCR using the human genomic DNA
as a template. Forward and reverse primers of 59-taatacgactcacta-
tagggaagtttctttcagagagttaagtta-39 comprised of a T7 promoter
sequence (20 bps) and a 59 25 nucleotide portion of the hFIX-AIE
region spanning from nt 32119 through 32143 [5], and 59-
tagaatggcttattgcttccattatatgt-39(nt 32239–32267), respectively,
were used. The template DNA fragment (149 nucleoside residues
in length: 59-aagtttctttcagagagttaagttattttatatatataatatatatataaaatata-
taatatacaatataaatatatagtgtgtgtgtgtatgcgtgtgtgtagacacacacgcatacaca-
catataatggaagcaataagccattcta-39) was then transcribed, generating
the corresponding hFIX-AIE RNA. Mouse FIX-AIE RNA (50
nucleosides in length: 59-gaaatcattaatttaatcatattggtaatatatatatatta-
tatctctaa-39) was produced by using a chemically synthesized DNA
fragment, 59- taatacgactcactatagggaaatcattaatttaatcatattggtaatatata-
tatattatatctctaa-39, comprised of a T7 promoter sequence (19 bps)
and the mFIX-AIE sequence (50 bps) spanning a region nt 2056
through nt 2105 of the mFIX gene (Genebank accession number:
M23109). Transcriptional reaction with each of these AIE DNA
templates was carried out in a reaction mixture (final volume of
20 ml) composed of 2 ml of 10x transcription buffer provided in the
Ambion kit,2 mlofea ch75mMAT P,GT P,CT P,4ml a [
32P]UTP
(GE Healthcare, 800 Ci/mmol), 1 mg hFIX-AIE or mFIX-AIE
template DNA and 2 ml of T7 MEGA shortscript enzyme mix. The
reaction mixture was then added with 1 ml of RNase-free DNase
solution, incubated for 15 min at 37uC and subjected to
electrophoresis using a 6% polyacrylamide urea gel. The gel was
then exposed to an X-ray film for 10 sec, and gel areas containing
radioactivity were precisely located by matching with the autora-
diogram and excised. The gel pieces recovered were then incubated
in a probe elution buffer (Ambion) at 37uC overnight. Non-
radioactive AIE RNA probes were prepared in a similar manner by
using non-radioactive nucleosides in transcription reaction.
Electrophoretic mobility shift assay (EMSA) with
32P-AIE
RNA
EMSA with an AIE RNA probe was carried out as described by
Cok et al. [10] with some modifications. NEs were prepared from
the mouse liver tissues (C57BL/6J mice) at 6 months of age as
previously described [1]. Aliquots (20,000 cpm) of
32P-AIE RNA
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9 cpm were
incubated for 50 min on ice with 2.5, 5 or 10 mg of NEs in the
presence of 0.2 mg of yeast RNA and 15 U RNase inhibitor in
EMSA binding buffer (10 mM Tris-HCl, 50 mM NaCl, 5%
glycerol, 1 mM DTT, 1 mM EDTA). The reaction mixture was
then added with 8 ml loading buffer, and subjected to EMSA on a
10% non-denaturing polyacrylamide gel. The gel was scanned
with a Storm 860 PhosphorImager (GE Healthcare). For
competitive EMSAs, non-radiolabeled RNA probe in various
molar excesses over that of
32P-labeled RNA probe was added to
the reaction mixture containing NEs 5 min prior to addition of the
radiolabeled probe. The rest of EMSA was performed as described
[10].
UV cross-linking, RNase-treatment and analysis by
sodium dodecylsulfate polyacrylamide gel
electrophoresis (SDS-PAGE) of
32P-hFIX-AIE RNA/nuclear
proteins complex
UV-crosslinking, RNase treatment and analysis by SDS-PAGE
of
32P-hFIX-AIE RNA/nuclear proteins complex were performed
as follows. Liver NEs (10 mg) was incubated with
32P-hFIX-AIE
RNA probe (approximately 1610
6 cpm/10 ml) in a similar
condition as described above. The reaction mixture was then
exposed to UV light for 30 min on ice (UV Stratalinker 1800,
Stratagene), followed by incubation with 2 ml of RNase T1 (5 U/
ml) (Ambion) for 20 min at 25u C. The reaction mixture was then
added with 8 ml SDS loading buffer (0.125 M Tris-HCl, 4% SDS,
4% 2-mercaptoethanol, 0.02% BPB, 20% glycerol), and subjected
to SDS-PAGE using a 10% polyacrylamide gel in the presence of
0.1% SDS. SDS-PAGE gels were scanned with a Storm 860 (GE
Healthcare). For competitive RNA EMSAs, non-radiolabeled
hFIX-AIE or mFIX-AIE RNA probe in various molar excesses
over that of
32P-labeled hFIX-AIE or mFIX-AIE RNA was added
to the reaction mixture containing NEs 5 min prior to addition of
the radiolabeled AIE RNA probe. The rest of conditions including
UV cross-linking, RNase T1 treatment and SDS-PAGE was same
as above. Competition assays with 10 mg each of homo-poly
nucleoside fragments, homo-poly(U), homo-poly(A) and homo-
poly (C), were done in a similar manner as for non-radiolabeled
AIE RNA competitors.
Preparative isolation of nuclear protein/
32P-hFIX-AIE RNA
complex by solution-phase isoelectric focusing (IEF) and
two dimensional electrophoresis (2DE)
For identification of the hFIX-AIE RNA binding protein(s),
preparative RNA EMSA using 20 mg NEs was repeated in a
similar condition as for analytical scale RNA EMSA. Following
the UV cross-linking step, the reaction mixture was added with
2 ml RNase T1 (5 U/ml) and incubated for 20 min at 25u C. The
reaction mixture was subjected to a preparative SDS-PAGE using
NuPAGEH Novex Bis-Tris 4–12% ZOOMH Gel (Invitrogen,
Carlsbad, CA). The gel was exposed to an X-ray film at 4uC for 1
day. Radioactive areas of the gel containing the nuclear
protein/
32P-AIE RNA complex were excised and subjected to
electro-elution using an Amicon Centriruter microelectroeluter
(Millipore, Billerica, MA). The solution recovered was concen-
trated with a Centricon apparatus (Millipore). This procedure was
repeated to obtain a sufficient amount of nuclear protein/
32P-
labeled hFIX-AIE RNA complex for further analyses. The pooled
sample solution was then subjected to IEF using a ZOOMH IEF
Fractionator (Invitrogen), and solution fractions with radioactivity
were recovered, concentrated with a Centricon apparatus and
subjected to analytical 2DE. Its IEF (the first dimension) was
performed by using an IPG Runner system with a pre-casted
ZOOM strip of an appropriate pH range gradient, followed by
SDS-PAGE using ZOOM gels. The gel was then silver stained
and exposed to an X-ray film at 4uC for 1 to 6 days depending on
the radioactivity strength. For identification of a protein(s) bound
to the AIE RNA probe used, the central gel area of radioactive
spots visualized in autoradiogram was excised and in-gel digested
with trypsin (Promega, Madison, WI). Peptides generated were
then recovered by extracting with a solution of acetonitrile:water:-
trifluoroacetic acid (66:33:0.1 by volume), vacuum-concentrated
and cleaned with a Zip Tip C18 (Millipore). The peptide
containing fractions collected and dried were mixed with CHCA
matrix before applying to an AximaH CFR MALDI-TOF/MS
(Shimazu Biotech, Kyoto, Japan). PMF analysis was done with a
MASCOT server version 2.1 (Matrix Science, London, U.K.)
taking the UniProtKB mouse protein database (taxonomy: mus
musculus).
2DE analysis of mouse liver nuclear proteins
Mouse liver NEs (300 mg) were subjected to IEF using a 24 cm
immobiline DryStrip (pH 6–11) (BIO-RAD, Hercules, CA),
followed by SDS-PAGE using a pre-casted 10–16% gradient
polyacrylamide gels (BIO-RAD). Gels were then stained with
Colloidal Coomassie Brilliant Blue (CBB) and scanned by GS-800
scanner (BIO-RAD). Protein spots were analyzed with a PDQuest
software (BIO-RAD, version 7.1), and excised, destained in
50 mM ammonium bicarbonate/50% acetonitrile and dried in a
vacuum concentrator (Savant, Holbook, NY). Dried gel pieces
were then rehydrated with 5 ml of 20 ng/L trypsin in 10 mM
ammonium bicarbonate, and incubated at 30uC overnight. Mass-
spectrometric analyses of the tryptic peptide samples were carried
out as described above except by using an AXIMAH MALDI-
TOF2 (Shimadzu Biotech).
Construction of recombinant adenovirus harboring
siRNA
Six separate candidate sequence sites of the AIE RNA binding
protein gene were selected by utilizing the siRNA design support
system R3 program (Takara Bio, Inc., Shiga, Japan) for
constructing an optimal siRNA expression unit against the gene.
Double stranded (ds) 19 or 20 nt-long sequences corresponding to
these sites were synthesized by mixing complementary oligonu-
cleotides containing a loop sequence (ctgtgaagccacagatggg) with
BamH1 and Hindz sticky ends at 59 and 39 ends, respectively,
thus forming a short hairpin RNA against the protein RNA. The
expression units encoding siRNAs against to the target protein
were cloned into pBAsi-mU6 Neo DNA vector (Takara). The
efficacy of each siRNA was assessed in 293 cells co-transfected
with the target binding protein expressing plasmid (0.1 mg) and its
siRNA expressing plasmid (0.3 mg). An expression vector unit for
the target protein, was prepared by RT-PCR with the total mouse
liver RNA as a template, followed by insertion into the GatewayH
pDESTTM 26 Vector using the Mammalian Expression System
with GatewayH Technology kit (Invitrogen). All measurements of
each siRNA test sample were done in duplicated RT-PCR. After
subtracting the PBS-saline control background, the results were
normalized to that of GAPDH (control), and averaged. The most
effective siRNA identified in suppressing the target protein mRNA
level was then cloned into pBAsi-mU6 Neo vector, and digested
with EcoRV, thus releasing a siRNA-encoding fragment. The
fragment was then inserted into a cosmid pAxcwit vector (Takara
Bio) at a SwaI site, and the cosmid vector generated was used for
producing recombinant adenoviral particles harboring the highly
effective siRNA expression unit with a Takara adenovirus
AIE Binding Protein
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by CsCl gradient centrifugation and stored at 280uC until use.
Control recombinant adenoviral particles harboring a scrambled
siRNA of the above selected siRNA or a siRNA against GFP gene
were similarly constructed.
Recombinant adenoviral particles harboring siRNA expression
unit against the target protein ranging from 8.4610
9 pfu in 100 ml
PBS were administered into tail veins of mice (C57BL6/J) at 12–17
month of age (n=4 for each experimental condition). Animals were
then sacrificed on day 4 and 14 post-viral injection,their liver tissues
removed and quick frozen on dry ice, and stored at –80uC until use.
TotalRNAswerepreparedfromthesetissuesbyaprocedure ofacid
guanidium phenol chloroform. PCR primers and TaqMan probe
used for the target protein in these quantitative real-time RT-PCR
assays were 59-TGTCAGGAAAGCTGCAGGTTACT-39 and 59-
CATCGTTCCTTCTGTGGCAGATT-39, and 59-FAM-CATC-
GTGCACCGCAA-MGB-39, respectively. Similarly, for b–actin
(control), 59-TCCACCTTCCAGCAGATGTG-39 and 59-CAG-
TAACAGTCCGCCTAGAAGCA, and 59-FAM-CATCGTG-
CACCGCAA-MGB-39 were used, respectively. RT-PCR Results
were normalized to that of b–actin mRNA.
Analysis of siRNA effects on hFIX expression in HepG2
cells
HepG2 cells were cultured in Dulbecco’s modified eagle
medium (DMEM) as previously described. The cells were
transfected with a mixture of hFIX minigene expression vector, -
416FIXm1/1.4 (hFIX expression vector containing AIE) or with -
416FIXm1 (hFIX expression vector without AIE) [1], and
pCH110 (b-galactosidase expression vector) at a 10:1 (w/w) ratio
(total 3 mg/well of 6-well plates) with Fugene 6 (Roche
Diagnostics) as previously described [1]. After 1 hr of transfection
reaction, the cells were added with recombinant adenoviral
particles (1.7610
7 pfu/ml in PBS-saline) at 2, 20 and 100 MOI,
and incubated at 37uC for 1 hr under gentle rocking every 10 min.
The medium was then switched to fresh DMEM and incubation
continued for 48 hr. Human FIX produced to the medium was
then quantified by hFIX-specific ELISA as previously described
[1].
Ribonuclease protection assay (RPA)
RPA for quantifying the mRNA level of hFIX-AIE RNA
binding nuclear protein was performed using a RPA kit
(Ambion) according to the manufacturer9s instruction. Total
RNAs of liver tissues of mice (C57BL6/J) at various ages (n=4
per age point) were prepared by an acid guanidium phenol
chloroform procedure [28]. The antisense DNA probe of the
protein mRNA was prepared by PCR amplification. Mouse b-
actin DNA (pTRI-Actin) provided in a RPA kit and 18S DNA
(pTRI-RNA, Ambion) were used as the controls in RPA.
Antisense
32P-labeled cRNA probes were generated using a
MEGAscript in vitro transcription kit (Ambion) and a [
32P]-UTP.
Hybridization was performed by incubating an aliquot of total
liver RNAs (10 mg) with
32P-labeled probe (approximately 1610
6
cpm/10 ml) for overnight at 42uC. The resulting hybridized
mixture was digested with a mixture of RNase A (2.5 units/ml)
and RNase T1 (100 units/ml) in RPA kit. The final precipitates
obtained were then dissolved in gel loading buffer, and subjected
to SDS-PAGE using a 6% polyacrylamide gel with 8M urea. The
gel was transferred onto a Whatmann 3 MM paper, dried and
exposed to an imaging plate (Fuji Film, Tokyo, Japan). The plate
was then scanned and quantified for radioactivity with a Storm
860 (GE Healthcare) using a NIH imaging program.
Western blot analysis
Liver NEs (10 mg/assay) prepared as described above from
C57BL/6J mice at various ages (n=10 per age point) were added
with 20 ml SDS loading buffer, and its protein concentration was
measured by the BCA method [29] and appropriately adjusted
with the loading buffer for SDS-PAGE using a 10% gel. The rest
of Western blotting procedure was performed according to the
standard method using horseradish peroxidase-conjugated anti-
rabbit antibody for protein detection with the ECL assay system
(GE Healthcare) [30]. Quantification of bands was done by using a
Bio-imaging analyzer LAS 1000 with Image Gauge Ver. 3.4X
software (Fuji film).
Supporting Information
Figure S1 MS/MS analysis of the peptide fragment from a mass
peak of m/z 1990.8. The fragmentation spectra of the peptide (aa
356 through 377, SSGSPYGGGYGSGGGGSGGYGSR) of
mouse hnRNP A3 are shown at the lower panel. Annotated ions
as nominal m/z values and results from fragmentation of an amide
bond with charge retention on the carboxyl end (y series ion) or
amino terminus (b series ion) are shown. Mascot scores for possible
phosphorylation site at Ser 359, Ser 357, Ser 356, Ser 367 are
138.6 (Expect value, 1.1 e-12), 125.8 (2.1 e-11), 123.4 (3.7 e-11),
38.2 (0.012), respectively. These data indicated that Ser 359 is the
most likely phosphorylation site. Fragment ions, y19-98, y20-98,
b4-98, b5-98, b9-98, b10-98, b13-98, b19-98 and b21-98 showed
a loss of 98-Da in mass corresponding to a phosphate group.
Fragment ions b2 and y18 indicated that a phosphate group is not
present in the SS dipeptide sequence (Ser 356 through Ser 357)
and PYGGGYGSGGGGSGGYGSR (Pro 360 through Arg 377).
Found at: doi:10.1371/journal.pone.0012971.s001 (1.30 MB EPS)
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